# GIMAP8

## Overview
GIMAP8 is a gene that encodes the protein GTPase, IMAP family member 8, which is part of the GTPases of the immunity-associated protein family. This protein is characterized by its unique structure, featuring three potential GTP-binding domains, which is atypical among GTPases and suggests a specialized functional role within its family (Webb2014Generation). GIMAP8 is predominantly expressed in mature lymphocytes and is involved in the regulation of apoptosis, particularly in T cells, where it exerts an anti-apoptotic effect (Webb2014Generation). The protein is localized to cellular organelles such as the endoplasmic reticulum, Golgi apparatus, and mitochondria in overexpression studies, although its native localization remains uncertain (Webb2014Generation). GIMAP8 has been implicated in various cancers and immune-related disorders, highlighting its potential as a prognostic biomarker and its involvement in the tumor immune microenvironment (Zhang2023Prognostic).

## Structure
GIMAP8 is a member of the GTPases of the immunity-associated protein family, characterized by its unique structure within the family due to the presence of three potential GTP-binding domains, known as G-domains. This feature is rare among GTPases and suggests a distinct functional role for GIMAP8 compared to other family members (Webb2014Generation). The protein consists of 688 amino acids and has a molecular weight of approximately 77 kDa (mukadam2019investigation).

GIMAP8 is predicted to be cytosolic, although some evidence suggests it may be loosely bound to membranes (mukadam2019investigation). When overexpressed in CHO-K1 cells, GIMAP8 localizes to the endoplasmic reticulum, Golgi apparatus, and mitochondria, though the localization of the native protein remains undetermined (Webb2014Generation). The protein's structure includes an AIG1 domain, a characteristic feature of the GIMAP family, which is involved in defense responses (Webb2014Generation).

The specific details of GIMAP8's primary, secondary, tertiary, and quaternary structures, as well as any post-translational modifications or splice variant isoforms, are not provided in the available literature. The protein's anti-apoptotic properties have been noted, although these findings have not been consistently replicated (mukadam2019investigation).

## Function
GIMAP8 is a member of the GTPases of the immunity-associated protein family, which is predominantly expressed in mature lymphocytes. It is characterized by its three potential GTP-binding domains, which is unusual among GTPases, suggesting a unique function within its family (Webb2014Generation). GIMAP8 is highly expressed in thymus tissue and mature lymphocytes, with weaker expression in heart, skin, and lung tissues (Webb2014Generation). The protein localizes to the endoplasmic reticulum, Golgi, and mitochondria in overexpression studies, although the localization of native GIMAP8 remains unclear (Webb2014Generation).

Functionally, GIMAP8 is involved in the regulation of apoptosis in lymphocytes. It exerts an anti-apoptotic effect, particularly in mature T cells, by delaying apoptosis in response to stressors such as dexamethasone and gamma-irradiation (Webb2014Generation). This suggests a role in maintaining lymphocyte survival under certain conditions. GIMAP8 may also influence the response to the chemokine Migration Inhibition Factor (MIF), which is crucial for B cell survival in the bone marrow (Webb2014Generation). Despite these roles, GIMAP8 is not essential for normal T and B cell development, indicating that its function may be redundant or compensated by other proteins (Webb2014Generation).

## Clinical Significance
GIMAP8, a member of the GTPase family, has been implicated in various cancer types due to alterations in its expression levels. In breast cancer, GIMAP8 is significantly upregulated in women with trisomy 21 who do not have breast cancer, suggesting a potential tumor-suppressive role (Mégarbané2020Transcriptomic). In non-small cell lung cancer, GIMAP8 expression is downregulated, which may be associated with cancer progression (Li2021Integrative). In clear cell renal cell carcinoma (ccRCC), GIMAP8 is over-expressed in tumor tissues and is associated with immune cell infiltration, particularly CD4+ T cells, indicating its involvement in the tumor immune microenvironment (Zhang2023Prognostic). High expression levels of GIMAP8 in ccRCC are linked to longer overall survival, suggesting its potential as a prognostic biomarker (Zhang2023Prognostic).

GIMAP8 also plays a role in immune regulation, as its deficiency in mice leads to a reduction in recirculating B cells in the bone marrow and altered apoptosis in T cells, although it does not significantly affect overall immune responses (Webb2014Generation). These findings highlight the gene's potential involvement in immune-related disorders and cancer.


## References


[1. (Mégarbané2020Transcriptomic) André Mégarbané, David Piquemal, Anne-Sophie Rebillat, Samantha Stora, Fabien Pierrat, Roman Bruno, Florian Noguier, Clotilde Mircher, Aimé Ravel, Marie Vilaire-Meunier, Sophie Durand, and Gérard Lefranc. Transcriptomic study in women with trisomy 21 identifies a possible role of the gtpases of the immunity-associated proteins (gimap) in the protection of breast cancer. Scientific Reports, June 2020. URL: http://dx.doi.org/10.1038/s41598-020-66469-w, doi:10.1038/s41598-020-66469-w. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-020-66469-w)

[2. (Webb2014Generation) Louise M. C. Webb, John C. Pascall, Lucy Hepburn, Christine Carter, Martin Turner, and Geoffrey W. Butcher. Generation and characterisation of mice deficient in the multi-gtpase domain containing protein, gimap8. PLoS ONE, 9(10):e110294, October 2014. URL: http://dx.doi.org/10.1371/journal.pone.0110294, doi:10.1371/journal.pone.0110294. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0110294)

[3. (Li2021Integrative) Heng Li, Liping Ding, Xiaoping Hong, Yulan Chen, Rui Liao, Tingting Wang, Shuhui Meng, Zhenyou Jiang, and Dongzhou Liu. Integrative genomic expression analysis reveals stable differences between lung cancer and systemic sclerosis. BMC Cancer, March 2021. URL: http://dx.doi.org/10.1186/s12885-021-07959-6, doi:10.1186/s12885-021-07959-6. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12885-021-07959-6)

[4. (Zhang2023Prognostic) Mengjiao Zhang, Xu Zhang, Jing Hou, Xuemei Liang, and Ming Zhang. Prognostic and immune infiltration signatures of gimap family genes in clear cell renal cell carcinoma. Frontiers in Bioscience-Landmark, 28(11):308, November 2023. URL: http://dx.doi.org/10.31083/j.fbl2811308, doi:10.31083/j.fbl2811308. This article has 1 citations.](https://doi.org/10.31083/j.fbl2811308)

5. (mukadam2019investigation) An investigation of the interaction between the immune system GTPase GIMAP6 and an autophagy gene 8 homologue GABARAPL2. This article has 0 citations.